Leif Rune Skymoen

LMI er en bransjeorganisasjon for både store multinasjonale selskaper og små gründerselskaper som opererer i legemiddel/life science-området. Vi arbeider for medisinske fremskritt for bedre helse, vil sikre norske pasienter rask tilgang til gode og kostnadseffektive medisiner - og vil bygge næringsliv og skape flere arbeidsplasser.

Nansen Neuroscience Network is a knowledge network focusing on innovation in neurosciences by bringing industry and academia together. Neuroscience is on the threshold of discovering the underlying mechanisms for complex mental and cognitive functions, considered by many to be the most challenging and exciting questions in science. It is also one of the fastest developing areas of medical research, and one in which Norway excels and is making significant contributions. Nansen Neuroscience Network aims to be the driving force in connecting brain science and industry, creating smart solutions for individuals and society and improving quality of life through innovation, research and development of diagnostics, therapeutics and preventive measures.

LMI er en bransjeorganisasjon for både store multinasjonale selskaper og små gründerselskaper som opererer i legemiddel/life science-området. Vi arbeider for medisinske fremskritt for bedre helse, vil sikre norske pasienter rask tilgang til gode og kostnadseffektive medisiner - og vil bygge næringsliv og skape flere arbeidsplasser.

🆕 Farmastat is a part of Signum Life Science as of September 2025. Signum empowers life science companies in the Nordics to turn complex data into clear business decisions. With access to the most comprehensive pharmaceutical sales data in the region, we provide trusted insights in areas such as Real-World Evidence, Market Access, Market Insights, Sales Performance, and HCP engagement. Our team of 60+ specialists has been a reliable partner to the Danish pharmaceutical industry for nearly 50 years as part of Lif, the Danish Association of the Pharmaceutical Industry. Today, we continue to build on that legacy with local offices in Norway and Sweden, as well as strategic partnerships in Finland, to deliver trusted consulting and data solutions across the Nordics. Discover more at www.signumlifescience.com.

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals, and organizations – all working in the cancer field. They represent the entire oncology value chain, doing everything from exploratory research to selling therapeutics and diagnostics to global markets. Our Incubator Environment Around 30 of the members are gathered in the Oslo Cancer Cluster Incubator, a successful biotech cluster, situated in the Oslo Cancer Cluster Innovation Park. We share the innovation park with Ullern Upper Secondary School, the Cancer Registry of Norway, several innovative companies, and Oslo University Hospital. Please follow the incubator LinkedIn page for news about the incubator companies: https://www.linkedin.com/company/oslo-cancer-cluster-incubator/ Twitter and Facebook: @oslocancer info@oslocancercluster.no

LMI er en bransjeorganisasjon for både store multinasjonale selskaper og små gründerselskaper som opererer i legemiddel/life science-området. Vi arbeider for medisinske fremskritt for bedre helse, vil sikre norske pasienter rask tilgang til gode og kostnadseffektive medisiner - og vil bygge næringsliv og skape flere arbeidsplasser.

Nansen Neuroscience Network is a knowledge network focusing on innovation in neurosciences by bringing industry and academia together. Neuroscience is on the threshold of discovering the underlying mechanisms for complex mental and cognitive functions, considered by many to be the most challenging and exciting questions in science. It is also one of the fastest developing areas of medical research, and one in which Norway excels and is making significant contributions. Nansen Neuroscience Network aims to be the driving force in connecting brain science and industry, creating smart solutions for individuals and society and improving quality of life through innovation, research and development of diagnostics, therapeutics and preventive measures.